Greenwood-Van Meerveld et al
On the other hand, the clinical trials on semaglutide (Wegovy) for weight loss have been clear: On average, people taking that medication lose 15% of their body weight over 68 weeks compared to 2.4% of body weight in those taking a placebo
That's where Ro comes inthey make it easy
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 10 , 403412
But it cannot replace: consistent meal structure adequate protein intake fibre from whole foods micronutrient sufficiency stable blood sugar patterns reduced inflammatory food exposure Metabolism is built through daily behaviour
So here were taking a system, the incretin system, GLP-1 or GIP, or coming soon glucagon, and were boosting it in people who have regular levels